*Leo Kojima1, Kaoru Seiriki1, Hiroki Rokujo1, Takanobu Nakazawa2, Atsushi Kasai1,3, Hitoshi Hashimoto1,4,5,6,7
(1. Lab. Mol. Neuropharmacol., Grad. Sch. Pharmaceut. Sci., Osaka Univ., Osaka, 2. Dept. Biosci., Fac. Life Sci., Tokyo Univ. Agr., Tokyo, Japan, 3. Drug Innovation Center, Grad. Sch. of Pharmaceut. Sci., Osaka Univ., Osaka, Japan, 4. Mol. Res. Ctr. Child. Ment. Dev., United Grad. Sch. Child Dev., Osaka Univ., Osaka, Japan, 5. Inst. Datability Sci., Osaka Univ., Osaka, Japan, 6. Inst. for Open Transdisciplinary Res. Initiatives, Osaka Univ., Osaka, Japan, 7. Dept. of Mol. Pharmaceut. Sci., Grad. Sch. of Med., Osaka Univ., Osaka, Japan)
Keywords:AAV
Abstract password authentication.
A password is required to view the full text of the abstract. Please enter the following password.
PW: Neuro2024